BASIS OF PRESENTATION, MEASUREMENT AND CONSOLIDATION (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 19, 2023 |
Sep. 19, 2023 |
Nov. 30, 2024 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
|
| Accumulated deficit | $ 139,441,785 | $ 127,499,785 | $ 139,441,785 | $ 127,499,785 | ||||||||
| Working capital deficiency | $ 15,996,856 | $ 18,228,253 | $ 15,996,856 | 18,228,253 | ||||||||
| Proceeds from issuance of debt | $ 11,756,563 | $ 14,545,805 | ||||||||||
| Proceeds from short term debt | $ 635,000 | 853,030 | ||||||||||
| Debt conversion converted instrument amount | $ 2,962,386 | |||||||||||
| Conversion of convertible securities | 97,811 | 36,897 | ||||||||||
| Gross proceeds from issuance of common stock | $ 125,227 | $ 123,347 | ||||||||||
| Proceeds from Issuance of Common Stock | $ 125,227 | $ 119,285 | ||||||||||
| Placement fee percentage | 3.00% | |||||||||||
| Preferred stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||
| Net proceeds issuance costs | $ 1,732,532 | $ 2,825,000 | ||||||||||
| Series B Preferred Stock [Member] | ||||||||||||
| Preferred stock, shares issued | 220 | 220 | 385 | 180 | 385 | 180 | ||||||
| Preferred stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||
| Preferred stock convertible purchase price | $ 9,091 | $ 9,091 | ||||||||||
| Gross proceeds | $ 2,000,000 | |||||||||||
| Net proceeds issuance costs | $ 1,900,000 | $ 1,900,000 | ||||||||||
| Stock issued during period | 1,431,181 | 2,867,448 | ||||||||||
| Series B Preferred Stock [Member] | Preferred Stock [Member] | ||||||||||||
| Stock issued during period | 220 | 110 | 220 | |||||||||
| Stock issued during period, value | $ 925,000 | $ 1,732,532 | ||||||||||
| Economic Injury Disaster Loan [Member] | ||||||||||||
| Proceeds from issuance of debt | $ 499,900 | |||||||||||
| X | ||||||||||
- Definition Gross proceeds from issuance of common stock. No definition available.
|
| X | ||||||||||
- Definition Placement fee percentage No definition available.
|
| X | ||||||||||
- Definition Number of stock issued during the period convertible, shares. No definition available.
|
| X | ||||||||||
- Definition Working capital deficiency. No definition available.
|
| X | ||||||||||
- Definition The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|